NCT02207101View on ClinicalTrials.gov

Study to Assess the Effect of OXYJUN on Ejection Fraction and Markers of Cardiovascular Injury

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Cardiac Function in Young Athletes
Interventions
DIETARY_SUPPLEMENT

E-OJ-01 (OXYJUN)

DIETARY_SUPPLEMENT

Placebo

Trial Locations (1)

400053

Suburban Diagnostics, Mumbai

All Listed Sponsors
collaborator

Enovate Biolife Pvt Ltd

INDUSTRY

lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY

NCT02207101 - Study to Assess the Effect of OXYJUN on Ejection Fraction and Markers of Cardiovascular Injury | Biotech Hunter | Biotech Hunter